1. Amelioration of Dalton's lymphoma–induced angiogenesis by melatonin. Issue 6 (May 2017) Authors: Kumari, Rani; Rawat, Kavita; Kumari, Anupma; Shrivastava, Anju Journal: Tumor biology Issue: Volume 39:Issue 6(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma. Issue 3 (15th April 2020) Authors: Thylur, Ramesh P; Roy, Sanjit K; Shrivastava, Anju; LaVeist, Thomas A; Shankar, Sharmila; Srivastava, Rakesh K Journal: JGH open Issue: Volume 4:Issue 3(2020) Page Start: 351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Developing polyphenolic acetates as radiation countermeasure agents: current status and future perspectives. Issue 4 (April 2020) Authors: Venkateswaran, Kavya; Shrivastava, Anju; Prasad, Ashok K.; Parmar, Virinder S.; Dwarakanath, Bilikere S. Journal: Drug discovery today Issue: Volume 25:Issue 4(2020) Page Start: 781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. In Vitro study of green synthesized ZnO nanoparticles on human lung cancer cell lines. (2022) Authors: Rani, Nutan; Rawat, Kavita; Shrivastava, Anju; Ekta, ; Yadav, Sapna; Gupta, Kalpna; Saini, Kalawati Journal: Materials today Issue: Volume 49:Part 5(2022) Page Start: 1436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Inhibition of pancreatic cancer stem cell characteristics by α‐Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog. Issue 4 (3rd February 2019) Authors: Ma, Yiming; Yu, Wei; Shrivastava, Anju; Srivastava, Rakesh K.; Shankar, Sharmila Journal: Journal of cellular and molecular medicine Issue: Volume 23:Issue 4(2019) Page Start: 2719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application. Issue 3 (10th January 2023) Authors: Roy, Sanjit K.; Srivastava, Shivam; Hancock, Andrew; Shrivastava, Anju; Morvant, Jason; Shankar, Sharmila; Srivastava, Rakesh K. Journal: Journal of cellular and molecular medicine Issue: Volume 27:Issue 3(2023) Page Start: 365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SATB2 is a novel biomarker and therapeutic target for cancer. Issue 19 (4th September 2020) Authors: Roy, Sanjit K.; Shrivastava, Anju; Srivastav, Sudesh; Shankar, Sharmila; Srivastava, Rakesh K. Journal: Journal of cellular and molecular medicine Issue: Volume 24:Issue 19(2020) Page Start: 11064 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Self‐Assembly and Transport Behaviour of Non‐ionic Fluorinated and Alkylated Amphiphiles for Drug Delivery. Issue 35 (16th September 2022) Authors: Kumar, Anoop; Krishna, ; Sharma, Antara; Dhankhar, Jyoti; Syeda, Saima; Shrivastava, Anju; Sharma, Sunil K. Journal: ChemistrySelect Issue: Volume 7:Issue 35(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The immunosuppressive effects of a novel recombinant LipQ (Rv2485c) protein of Mycobacterium tuberculosis on human macrophage cell lines. (June 2017) Authors: Kumar, Anjani; Manisha, ; Sangha, Gurkamaljit Kaur; Shrivastava, Anju; Kaur, Jagdeep Journal: Microbial pathogenesis Issue: Volume 107(2017) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗